Observational Study
Copyright ©The Author(s) 2023.
World J Hepatol. Apr 27, 2023; 15(4): 577-584
Published online Apr 27, 2023. doi: 10.4254/wjh.v15.i4.577
Table 1 Clinical characteristics of 11 cases of chronic hepatitis B complicated with primary biliary cholangitis
No.
Sex
Age
TBIL
ALT
AST
ALP
GGT
TBA
Albumin (g/L)
AMA-M2
gp120
sp100
ANA
IgM
IgG
HBV DNA (Log)
Platelet (1 × 109/L)
Fatigue
Pruritus
1Woman4222.2875647671732.2+++-+4.2521.157.219.21++
2Man6045.22241751541163036.5+---1.2511.234.2512.66--
3Woman5213.5352457571241.2+---1.659.324.688.35--
4Man3715.522164647838.2+---1.428.655.3216.35--
5Man3916.0352465371237.9+---1.8710.32-15.32--
6Woman3716.3271874581436.4++---2.0111.566.1411.25--
7Man57422.424321576783714732.2+---4.3624.324.3513.65++
8Woman5220.4156871672242540.2+++-+0.9810.483.5714.25+-
9Woman3211.3251137263741.6+---1.149.654.2524.22--
10Woman2832.71815166891839.2----1.5813.64-21.03--
11Woman5125.6872618598938.1----1.6710.35-18.21--
Table 2 Changes of biochemical indexes before and after treatment

TBIL
ALT
AST
ALP
GGT
TBA
IgM
IgG
Before treatment20.4 (11.3-422.4)35 (18-243)24 (11-215)66 (37-767)58 (17-837)17 (8-147)1.65 (0.98-4.37)12.7 (8.6-24.3)
After treatment17.7 (6.7-21.2)27 (12-63)21 (15-43)47 (38-107)25 (16-42)9 (6-20)1.4 (1.1-2.5)11.3 (6.8-15.3)
Statistical value1.2232.3511.6561.3262.3691.6322.4350.931
P value0.2480.0410.1290.2140.0390.1340.0310.374
Table 3 Pathological characteristics of 11 cases of chronic hepatitis B complicated with primary biliary cholangitis
No.
II
BN
LI
DI
FDL
BIH
DU
HBsAg staining
HBcAg staining
METAVIR activity score
METAVIR stage
Ludwig stage
11-2++--++2F1I
21-1+-----1F1II
30-1++--+-1F1I
42+2+-+--+2F1II
50-1++--+-1F2I
61-1+-+-+-1F1I
73+2+++-++3F3II
82+1+-+---2F1I
91-1+-+++-1F4III
100-0++----0F0I
111-1+---+-1F0I